SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?


To: blessed who wrote (1934)10/26/1998 11:42:00 PM
From: EMF  Respond to of 4650
 
Did anyone notice that the latest press release did not contain the customary summary of ADOTs Business? or mabye it did.

EMF



To: blessed who wrote (1934)10/27/1998 12:32:00 AM
From: ksuave  Respond to of 4650
 
Interesting points, blessed. I'm still hoping that Guy, or someone, can explain how success of Biomoda will necessarily increase ADOT's share price. If Biomoda increases it's number of shares, is ADOT's investment diluted, or may they continue to accumulate shares until they have the agreed upon percentage of ownership? The more releases, the more interesting questions arise. Any 10Q in sight, or are we not that fully reporting?

The straight lines here are just getting too easy.

Richard



To: blessed who wrote (1934)10/27/1998 6:26:00 AM
From: thomas a. burke  Respond to of 4650
 
Blessed,

I concur with your thinking on ADOT/Biomoda. I would be in favor of doing some private placements(as Guy said could be done)over the next year or so. If Biomoda needs 10 million a year for 2 or more years, this tells me a few things:
1) Biomoda will not be selling enough, if any early detection kits to
raise enough working capital for the next few years.
2) Biomoda will drastically dilute their shares to raise 20 million
over the next two years.
3) ADOT will not generate revenues till next year(hope I am wrong).

It is my opinion that ADOT will continue to burn cash and watch as Biomoda stock is heavily diluted over the next two years. If this scenario plays out, then Les will know how the ADOT shareholders have felt for the last year.

Regards, Tom B.